Lineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2025 Earnings Call Transcript March 5, 2026 Lineage Cell Therapeutics, Inc.
Evogene Ltd. (NASDAQ:EVGN) Q4 2025 Earnings Call Transcript March 5, 2026 Evogene Ltd. misses on earnings expectations. Reported EPS is $-0.61 EPS, expectations were $-0.26. Operator: Welcome to ...
The Roundhill Generative AI and Technology ETF has produced more than twice the return of the S&P 500 since its inception.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results